The S&P 500 is headed for a sixth straight decline. Retail traders are calling it a "healthy pullback." Healthy things do not get six consecutive losses. Ask any hospital.
Meanwhile, no. Strike that. Johnson & Johnson advanced two key products today. That is the detail. Not the six red days. The two products.
Two. Out of a company that makes everything from Band-Aids to oncology drugs. J&J has a pipeline thicker than a Cleveland phone book, and the Investing Club is thrilled about two entries.
Here is the corporate statement J&J would issue if it were honest: "We moved some things forward. The things are products. Please do not ask about the talc."
The chart does not care. The chart sees six lower closes and draws a line under them. The chart has never read a pipeline update. The chart has never met a Phase III trial. The chart is the only one in the room doing its job.
Retail traders will read the J&J news and buy the dip on the sixth day. They will call it conviction. It is not conviction. It is a coupon-clipping instinct with a brokerage login.
Consider the logic. The market falls for six days. A pharmaceutical giant announces progress. Traders conclude the two events are related. They are not. One is a market. The other is a company. You have confused a weather report with a dentist appointment.
The Homestretch exists for the final hour of trading. Sixty minutes. Three thousand six hundred seconds to decide whether to buy the sixth decline or wait for the seventh. Technical analysts call this a "decision." Everyone else calls it a coin flip with a Bloomberg terminal.
Six straight declines. Two J&J products. Zero chance you read past the headline.
Your portfolio is a seven-day streak waiting to happen.
Photo by Olha Ivanova on Unsplash

Leave a Comment